These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25875354)

  • 1. Recent advances in atrial fibrillation and stroke.
    David Spence J
    Neurol Res; 2015 May; 37(5):381-4. PubMed ID: 25875354
    [No Abstract]   [Full Text] [Related]  

  • 2. Ischemic stroke on optimal anticoagulation with novel-oral anticoagulants compared with warfarin.
    Kim BJ; Kang HG; Lee DH; Kang DW; Kim JS; Kwon SU
    Int J Stroke; 2015 Aug; 10(6):E68. PubMed ID: 26202718
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulant treatment in patients with atrial fibrillation and ischemic stroke.
    Brunner Frandsen NS; Andersen AD; Ashournia H; Brandslund I; Kjærsgaard JO; Vilholm OJ
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1120-5. PubMed ID: 25881779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
    Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
    J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal trends in ischemic stroke and anticoagulation therapy among Medicare patients with atrial fibrillation: a 15-year perspective (1992-2007).
    Shroff GR; Solid CA; Herzog CA
    JAMA Intern Med; 2013 Jan; 173(2):159-60. PubMed ID: 23266657
    [No Abstract]   [Full Text] [Related]  

  • 6. Underuse of antithrombotic therapy caused high incidence of ischemic stroke in patients with atrial fibrillation.
    Yu HC; Tsai YF; Chen MC; Yeh CH
    Int J Stroke; 2012 Feb; 7(2):112-7. PubMed ID: 22103748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial Fibrillation and Stroke: It's About Point of View.
    Anderson DC; Asinger RW
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1118-9. PubMed ID: 25935313
    [No Abstract]   [Full Text] [Related]  

  • 8. Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials.
    Renda G; di Nicola M; De Caterina R
    Am J Med; 2015 Sep; 128(9):1007-14.e2. PubMed ID: 25910790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation.
    Liew A; Eikelboom JW; O'Donnell M
    Curr Opin Cardiol; 2012 Jul; 27(4):331-9. PubMed ID: 22573171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
    N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent development of anticoagulation in stroke prevention for atrial fibrillation].
    Suzuki S; Yamashita T
    Nihon Rinsho; 2014 Jul; 72(7):1282-6. PubMed ID: 25163322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation for stroke prevention in a Medicare population with atrial fibrillation.
    Miranda LS; Turkel RA; Ahmed O; Dent M; Dion C
    J Fla Med Assoc; 1997; 84(4):227-31. PubMed ID: 9342908
    [No Abstract]   [Full Text] [Related]  

  • 13. The king is dead (warfarin): direct thrombin and factor Xa inhibitors: the next Diadochian War?
    Diener HC; Eikelboom J; Granger CB; Hacke W
    Int J Stroke; 2012 Feb; 7(2):139-41. PubMed ID: 22264366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic use following transient ischaemic attack or ischaemic stroke among older Australians with atrial fibrillation.
    Sluggett JK; Caughey GE; Ward MB; Gilbert AL
    Intern Med J; 2014 Nov; 44(11):1134-7. PubMed ID: 25367727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The balance between stroke prevention and bleeding risk in atrial fibrillation: a delicate balance revisited.
    Lip GY
    Stroke; 2008 May; 39(5):1406-8. PubMed ID: 18323477
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticoagulation control in atrial fibrillation: optimizing risks and benefits.
    Alsheikh-Ali AA; Estes NA
    Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):72-3. PubMed ID: 20031792
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.
    Olesen JB; Sørensen R; Hansen ML; Lamberts M; Weeke P; Mikkelsen AP; Køber L; Gislason GH; Torp-Pedersen C; Fosbøl EL
    Europace; 2015 Feb; 17(2):187-93. PubMed ID: 25236181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of ischemic stroke from atrial fibrillation in Dijon, France, from 1985 to 2006.
    Béjot Y; Ben Salem D; Osseby GV; Couvreur G; Durier J; Marie C; Cottin Y; Moreau T; Giroud M
    Neurology; 2009 Jan; 72(4):346-53. PubMed ID: 19171832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should Patients With Ischemic Stroke or Transient Ischemic Attack With Atrial Fibrillation and Microbleeds Be Anticoagulated?
    Shoamanesh A; Charidimou A; Sharma M; Hart RG
    Stroke; 2017 Dec; 48(12):3408-3412. PubMed ID: 29114097
    [No Abstract]   [Full Text] [Related]  

  • 20. Choosing between warfarin (Coumadin) and aspirin therapy for patients with atrial fibrillation.
    Ebell MH
    Am Fam Physician; 2005 Jun; 71(12):2348-50. PubMed ID: 15999873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.